Elron Ventures Ltd · TASE:ELRN
Elron Ventures — Investor Presentation (November 2018)
26 slides from Elron Ventures's investor presentation, November 2018
Slide 1: Innovation – November 2018
INNOVATION November 2018
Slide 2: Disclaimer
This presentation is for information purposes only. By this presentation, Elron does not intend to solicit offers to purchase its securities and the presentation does not constitute an invitation to receive such offers. Elron may make improvements and/or changes in the features or content presented
Slide 3: Discover. Elron
DISCOVER. ELRON
Slide 4: Experience identifying opportunities and building technology leaders
+ WE HAVE MORE THAN YEARS EXPERIENCE IDENTIFYING OPPORTUNITIES, BUILDING TECHNOLOGY LEADERS, AND EXITING HOLDINGS + WE INVEST PRIMARILY IN EARLY STAGE COMPANIES + WE RELY ON A PROVEN STRATEGY OF HANDS‐ON INVOLVEMENT IN THE DAY‐TO‐DAY OPERATIONS OF OUR GROUP COMPANIES THE IDEA: to bridge the gap betw
Slide 5: 2018 investments, exit proceeds and liquid resources
Exit proceeds in the last 5 years * Investments in the last 5 years * Dividends distributed in the last 5 years 2018: $26m invested in 14 group companies*; exit proceeds of $21m*; liquid resources balance of $57m*; loss of $10.2m in Q1‐3/18 * Including RDC 5
Slide 6: OpenLegacy and cyber investment round
To deliver digital services from legacy To help enterprise security teams cope systems automatically, easily & rapidly with the mounting intensity of cyberattacks Automatic API generation in just Rapid & automatic detection, minutes investigation and remediation of security alerts 2016 $18M The inve
Slide 7: Medical device group companies and investments
Electrical stimulation-based treatment Rapid and automated microbiology Implant for cartilage and bone for ischemic stroke laboratory system regeneration in load-bearing joints 30% 70% by Elron & RDC 29% Our investment: $29m Our investment: $78m Our investment: $17m Endoscopic procedure that mimics
Slide 8: BrainsGate: ischemic stroke treatment
SPG STIMULATION STARTED WITHIN 24 HRS REDUCED DISABILITY IN A BROAD CATEGORY OF CORTICAL 2000 STROKE PATIENTS (50% OF TRIAL POPULATION) OUR INVESTMENT: 2005 • The longest clinically tested treatment window – on $29M $97M average, patients were treated 19 hrs after stroke onset • Performed by MDs (mo
Slide 9: Pocared: rapid automated microbiology
2004 OUR Pocared expects to conduct a trial to INVESTMENT: 2007 support FDA marketing approval $78M $122M SCP Vitalife Accurate but lengthy Quick but subjective Relies on culturing (inefficient & High rate of misdiagnosis & costly process; lab results can take mistreatment (resulting in days) compli
Slide 10: CartiHeal: cartilage and bone implant
Initiated IDE study 1 year ago 2009 OUR INVESTMENT: 2012 The study is currently ongoing in the US, EU, and Israel, with the $17M $51M purpose of an FDA PMA application Johnson & Johnson, Accelmed, aMoon, Bioventus To demonstrate the implant’s superiority over the surgical standard of care (microfrac
Slide 11: Endoscopic bariatric device company
2014 OUR INVESTMENT: 2016 Performed procedure on 13 Secured $2m from 2 $3.1M patients $6.1M new investors | LAST PATIENT FOLLOW‐UP Accelmed, MTIP, Techwald Most popular (58% of all bariatric procedures) Efficient (>50% weight loss at 3‐5+ yrs) Invasive Complicated Expensive Irreversible Making effec
Slide 12: Coramaze: transcatheter mitral valve repair
| | Transfemoral, fatigue tested device, 2013 successfully implanted in animals Design freeze of device for OUR (>90 days) first-in-human trial INVESTMENT: 2015 €5.2M €10.8M HEALTHY MITRAL VALVE fMR The valve closes when the An enlarged left ventricle HTGF, SeedCapital, MTIP left ventricle contracts
Slide 13: Notal Vision: AMD home monitoring
2000 MORE THAN EXAMS OUR COMPLETED WITH ForeseeHOME INVESTMENT: 2002 USER BASE UP OVER LAST 2 YRS $13.5M $87M EMPLOYEES Ganot, Evergreen 2019 GOALS: Increase sales & launch Home OCT device The progression from dry AMD to wet AMD can occur rapidly and lead to severe vision To save the eyesight of Age
Slide 14: Cybersecurity and software group companies
Automated API integration platform that speeds digital transformation 32% by RDC Our investment: $8.2m Cyber intelligence platform Behavioral biometrics-based Automated phishing Universal security and that automatically & covertly user authentication for mobile prevention, detection & management pla
Slide 15: OpenLegacy: automated API integration
2013 OUR INVESTMENT: 2014 $8.2M $30.7M The investment will be used to accelerate the company’s growth >20 customers worldwide, incl. 1st-tier insurance & banking corps To deliver digital services from legacy systems automatically, easily & rapidly SLASHING LEGACY API OUR Automatic API generation for
Slide 16: Flattening & Decoupling the Stack
Flattening & Decoupling the Stack 16
Slide 17: Global Tier-1 Use Case
24 Global Tier-1 API production using Use Case previous solution Money Transfer API weeks Production 25 20 15 10 5 1 • • • • API performance: 5 times faster than existing solution Over 75% reduction in labor cost (20 vs. 120 FTEs) Bypassing multiple middleware products ($mn savings) Path to cloud mi
Slide 18: Sixgill: dark web intelligence
2014 OUR INVESTMENT: 2016 $3.5M $4.5M REVENUE GROWTH & OPERATIONAL EXPANSION Terra Venture Partners USE To monitor & analyze Dark Web activity #OlympicHackingRio ISIS threats in order to provide organizations with real time OUR Sixgill alerted the customer Sixgill revealed threats made alerts & acti
Slide 19: SecuredTouch: behavioral biometrics
2015 OUR INVESTMENT: 2016 $4.5M $11.9M SECUREDTOUCH RECEIVED A STRATEGIC Global Village Advisory, INVESTMENT FROM ARVATO FINANCIAL SOLUTIONS Upwest Labs, Arvato Financial Solutions IN AN $8M ROUND BEHAVIORAL BIOMETRICS To mitigate advanced digital fraud techniques, and to allow continuous & friction
Slide 20: Phishing prevention platform
2014 OUR INVESTMENT: 2015 Significant Operational 2 FORTUNE $2.5M $7.5M revenue growth shift to U.S. 500 customers K1 Investment Management Bypass gateway Go Lure To protect enterprises from cyber defenses undetected clicks phishing attacks OUR uses human & machine intelligence to Automated phishing
Slide 21: Universal network security platform for data centers
2018 OUR 2016 Raised $7m in a round led by a new INVESTMENT: 2016 investor $3.9M $11.4M Intel Capital, CE Ventures THE FIRST UNIVERSAL NETWORK SECURITY PLATFORM FOR MODERN DATA CENTERS Real-time To provide universal security for hybrid, visibility multi‐cloud and multi‐compute data centers OUR Netwo
Slide 22: Cynerio: connected healthcare security
2017 2018 OUR INVESTMENT: 2018 Raised $3.6m in a round led by a new investor $2.3M $6.6M Cisco and Cynerio partnered to Accelmed improve medical device security: The Cisco-Cynerio integrated solution provides a clear understanding of the risk type and priority for each connected device To protect co
Slide 23: Kindite: cloud encryption platform
2017 KINDITE’S TECHNOLOGY WAS SUCCESSFULLY PILOTED BY OUR 2 LEADING CLOUD SERVICE PROVIDERS & A FIRST‐TIER INVESTMENT: 2018 FINANCIAL INSTITUTION $2.5M $3.5M CE Ventures Open up the cloud for enterprises and regulated organizations, overcoming risks of OUR Kindite solves the long‐standing challenge
Slide 24: OzCode: Debugging-as-a-Service
2013 OZCODE RAISED $3.5M FROM RDC & TPY CAPITAL, AND OUR INVESTMENT: 2018 LAUNCHED THE INDUSTRY’S FIRST DEBUGGING‐AS‐A‐ $2.5M $3.5M SERVICE (DaaS) TPY Capital OzCode’s plaform offers time travel production debugging to provide the fastest insight on how and To significantly cut debugging time so why
Slide 25: Thank You
THANK YOU. HLRON elron.com
Slide 26: Holdings in companies and book value
Holdings in companies 1 Book value at Amount invested Sep. 30, 2018 ($m) ($m) Associates and consolidated companies: Pocared (59%) 10.0 67.7 BrainsGate (30%) 0.3 29.1 CartiHeal (29%) 4.4 16.9 Others 10.7 31.7 Companies presented at fair value: Notal Vision (15%) 10.2 13.5 Others 7.0 21.0 Total Holdi
Elron Ventures — Investor Presentation (November 2018) on 6ix